Smoking is a major cause of respiratory conditions. To date, the genetic pleiotropy between smoking behavior and lung function/chronic obstructive pulmonary disease (COPD) have not been systematically explored. We leverage large data sets of smoking behavior, lung function and COPD, and addressed two questions, (1) whether the genetic predisposition of nicotine dependence influence COPD risk and lung function; and (2) the genetic pleiotropy follow causal or independent model. We found the genetic predisposition of nicotine dependence was associated with COPD risk, even after adjusting for smoking behavior, indicating genetic pleiotropy and independent model. Two known nicotine dependent loci (15q25.1 and 19q13.2) were associated with smoking adjusted lung function, and 15q25.1 reached genome-wide significance. At various suggestive p-value thresholds, the smoking adjusted lung function traits share association signals with cigarettes per day and former smoking, substantially greater than random chance. Empirical data showed the genetic pleiotropy between nicotine dependence and COPD or lung function. The basis of pleiotropic effect is rather complex, attributable to a large number of genetic variants, and many variants functions through independent model, where the pleiotropic variants directly affect lung function, not mediated by influencing subjects' smoking behavior.
function (e.g. FEV 1 , FVC and FEV 1 /FVC ratio) are traits closely related to COPD, in fact, lung function parameters are often used in defining COPD cases 6 . Three key parameters are commonly used in characterizing lung function: expired volume in 1st second (FEV 1 ), forced vital capacity (FVC) and FEV 1 /FVC. FVC is the volume of air that can forcibly be blown out after full inspiration 19 , and is the most basic maneuver in spirometry tests. FEV 1 is the volume of air exhaled in the first second during forced exhalation after maximal inspiration 19 . FEV 1 /FVC is the ratio of these two values, where the ratio ≥ 80% is considered normal 19 . To date, 97 independent genetic loci were identified influencing lung function traits (FEV 1 , FVC and FEV 1 /FVC) 6 .
Genetic pleiotropy is the phenomenon where a DNA variant influences multiple traits 20 . Proposed by our group and others, available GWAS summary data can be used to detect genetic pleiotropy and pinpoint the variants, gene and pathways underlying the shared etiology [21] [22] [23] . Given smoking is a strong cause of COPD and lung function decline, genetic variants associated with smoking behavior or nicotine dependence (ND) are likely also in association with lung function (LF), which can be viewed as genetic pleiotropy. The genetic pleiotropy could have two possible mechanisms: (1) a genetic locus causes ND and then in turn causes LF decline (Fig. 1A) ; and (2) a genetic locus causes ND and LF decline independently (Fig. 1B) . These two mechanisms can be distinguished by testing the association between genetic locus and smoking adjusted LF (ie, LF adj ). If mechanism (1) is true, the ND locus will show no association with LF adj (Fig. 1C) .
A recent GWAS meta-analysis employed 48,943 UK Biobank individuals in discovery phase and 95,375 individuals in follow-up phase, and increased the independent signals for lung function from 54 to 97 6 . Importantly, the study carefully adjusted for smoking behavior, and among smokers, the pack-year was also adjustment 6 . The GWAS results of smoking-adjusted lung function offer a unique opportunity to decipher the genetic pleiotropy between nicotine dependence and function as well as the etiological mechanisms.
Results
Genetic predisposition of nicotine dependence is associated with COPD risk. We leverage the individual level phenotype (COPD affected status and smoking behavior) and genotype data of COPDgene cohort (Materials and Methods) to test association between genetic predisposition of nicotine dependence (quantitatively summarized as polygenic score, or PGS) and COPD risk. On each COPDgene study subject, we computed the PGS for ND CPD trait (i.e., PGS ND-CDP ). The PGS ND-CDP compiled at 1e-3 and 1e-4 p-value thresholds were associated with that COPD affected status at p-value 0.025 and 1.03e-6, respectively (Table 1) , indicating significant pleiotropy of ND and COPD. The positive association coefficient indicate genetic predisposition of higher cigarettes per day leads to higher COPD risk ( Table 1) . PGS of former smoking (ie, PGS ND-FORMER ) were also associated with COPD, and the negative coefficient suggested the genetic predisposition of smoking cessation reduced COPD risk. Next, we adjusted the smoking covariates and found the PGS ND-CDP and PGS ND-FORMER were still associated with COPD (Tables 2 and 3 ). Importantly, the association p value and coefficient were little changed before and after adjustment, indicating an independent pleiotropy model ( Fig. 1B) , where the effect of PGS ND-CDP and PGS ND-FORMER on COPD risk was not mediated by smoking behavior of the study participants.
Nicotine dependence genome-wide significant loci and their association with lung function (LF). Firstly, we retrieved six independent ND GWAS loci of genome-wide significance (p < 5e-8) in European ancestry 24 from the NHGRI-EBI catalog 25 , and examined the association between these loci and smoking adjusted lung function (LF adj ) in UKBB meta-analysis cohort ( Table 4 ). In UKBB study, the smoking status was adjusted with the regression model in the form of indicator variables denoting current smoker, and denoting former smokers; as well as quantitative variable denoting pack-year (in smokers). At nominal p value (≤0.05), two ND loci showed association with at least one LF adj traits (FEV 1 , FVC, and FEV 1 /FVC Ratio). The lead SNP, rs1051730, of the 15q25.1 locus was strongly associated with all three LF adj trait, and its association with smoking adjusted FEV 1 reached genome-wide significant (p = 5e-8), further, the 19q13.2 locus, known in association with COPD 26 , is also associated with smoking adjusted FEV 1 ( 32 , 8p11.21 10 were summarized by NHGRI-EBI GWAS catalog. The reported lead SNP was checked for association with smoking adjusted lung function in UKBB GWAS meta-analysis 6 . ND, nicotine dependence; LF, lung function.
influence ND and LF independently ( Fig. 1B) . In contrast, four genome-wide significant ND loci (10q23.32, 8p11.21, 11p14.1, 9q34.2) showed no association with LF adj traits ( Table 4 and Fig S1) , suggesting causal pleiotropy model ( Fig. 1 A) , where the genetic variants influence LF, mediated by smoking behavior.
Identification of SNPs associated with lung function and nicotine dependence at suggestive threshold.
There is a general consensus among GWAS studies that a p-value less than 5e-8 corresponds to genome-wide significance 24 . NHGRI-EBI GWAS catalog focuses on highly significant loci, but true association loci may only show suggestive p values given the limited power in GWAS. We leverage the summary data of with UKBB smoking adjusted LF (LF adj ) and TAG ND (Materials and Methods). Applied various p thresholds (ranging from 1e-8 to 1e-2), we identified SNPs in associated with LF adj or ND (Table S1 ). The UKBB LF adj GWAS yield many SNPs highly significantly associated with smoking adjusted FEV 1 , FVC and FEV 1 /FVC Ratio. On the other hand, the TAG ND study captured strong genetic signals for CPD (cigarettes per day) and moderate signal for former smoking (Table S1 ). But no SNP associated ever smoking or log-onset at p < 1e-7 level, indicating these two traits either are not controlled by genetic factors or the TAG study did not have sufficient power (Table S1 ).
Among the ~2 million SNPs tested in both LF adj and ND GWAS studies, the proportion of associated SNPs at any given p-value threshold was greater than alpha level ( Table 5 ). For example, at p-value ≤ 1e-3 threshold, 11,716 SNPs and 2,791 SNPs were associated with FEV 1 and CPD, respectively, and 71 SNPs were associated with both trait, which is substantially greater than random chance (enrichment fold = 4.61). In fact, we observed excess overlapping of FEV 1 and CPD GWAS SNPs were across multiple p-value thresholds ( Table 5 and Fig. 2 ). Further, at p value ≤ 1e-3 threshold, 139 SNPs were associated with both FEV 1 and former smoking ( Table 6) , 11.8 folds of enrichment than random chance. While, GWAS signals of ever smoking and smoking onset showed little or very modest overlap with LF adj GWAS (Tables S2 and S3 ). The SNPs associated with at least one of the nicotine dependence and lung function traits (cigarettes per day, former smoking, FEV 1 , FVC, FEV 1 /FVC) at p value ≤ 1e-3 level were listed in Table S4 ; while SNPs associated with all of the five nicotine dependence and lung function traits were detailed in Table S4 .
Association direction of shared LF adj and ND SNPs. The shared LF adj /ND SNPs can be stratified into categories according whether the allele associated with higher LF adj trait is also associated with higher ND trait or ND event odds (ie, consistent direction SNP) or vice versa (ie, divergent direction SNP). We stratified the shared LF adj /ND SNPs by directions, and found all three LF adj traits primarily have divergent direction with CDP (Table 5 ). At 1e-3 threshold, 71 SNPs are shared by FEV 1 and CPD, where 65 SNPs (91.55%) with divergent directions (binomial p value = 4.34e-13), indicating alleles lead to higher smoking quantity (cigarettes per day) tends to associated with lower LF adj traits. In contrast, the LF adj traits primarily have consistent direction with former smoking (Table 6 ). At 1e-3 threshold, 193 SNPs were shared by FEV 1 and former smoking, and only 21 SNPs (10.88%) with divergent directions but 172 SNPs are of a consistent direction (binomial p-value = 4.34e-13), indicating alleles lead to smoking cessation tend to associated with higher LF adj traits.
Further, we stratified the SNPs into the consistent direction SNP and divergent SNP subcategories, regardless of GWAS test p-values criteria (Tables S5-S8 ). We found the overlap of CPD and LF adj GWAS signals primarily occur among the SNPs of divergent allele direction, and observed little overlap among the SNPs of consistent allele direction. For example, at a GWAS p-value < 1e-3, SNPs of divergent allele direction for FEV 1 and CPD showed substantial overlap (6.94 fold enrichment), in contrast, the overlap for SNPs of consistent allele direction were not different from random chance.
Gene ontology influenced by the shared SNPs of LF adj and ND. Shared LF adj /ND SNPs may undergo complicated pathways and lead to disease risk. Identifying the genes influenced by such shared SNPs would be the key step elucidating the SNPs' function and pathogenic pathways. To investigate potential functional impacts of LF adj /ND shared SNPs, we used a "relax" p-value threshold criterion of 1e-2 for GWAS. Among the 826 shared FEV 1 -CPD SNPs, 375 are characterized by having consistent direction and 451 are characterized by divergent direction. Based on SNP position and dbSNP annotation 27 , we identified genes located with on or near the share GWAS SNPs of LF adj and ND, and then carried out the Gene Ontology (GO) cellular processes enrichment analysis using METACORE suite (Fig. 3) . The top 10 enriched processes (p-value ≤ 1e-6) were regulation of synapse vesicles as well as regulation of respiratory systems, highly relevant to lung function and nicotine dependence.
Co-localization of 15q25.1 locus underlying LF adj and ND. SNPs on 15q25.1 locus are associated with
both LF adj and ND at genome-wide significant level (Table 4 ). Also, the CHRNA3-CHRNA5-CHRNB4 gene cluster in this locus is functional relevant to both traits. However, given that neighboring SNPs were often in tight linkage disequilibrium (LD), the overlap of GWAS signals do not guarantee that the disease risks of the two traits are caused by the same variant. Recently developed methods allow more advanced integration of GWAS summary data to co-localize GWAS signals 28 . The co-localization methods 28 evaluated 5 hypotheses (Materials In the 1st column (plot A, E and I), we investigated on SNPs associated with cigarettes per day (CPD) at ≤1e-2 (red dots), ≤1e-3 (blue dots), ≤1e-4 (green dots), and ≤1e-5 (black dots); in the 2nd column (plot B, F and J), we investigated on SNPs associated with ever smoking (EVERSMK) at ≤1e-2 (red dots), ≤1e-3 (blue dots), ≤1e-4 (green dots), and ≤1e-5 (black dots); in the 3rd column (plot C, G and K), we investigated on SNPs associated with former smoking (FORMER) at ≤1e-2 (red dots), ≤1e-3 (blue dots), ≤1e-4 (green dots), and ≤1e-5 (black dots); in the 4th column (plot D, H and L), we investigated on SNPs associated with log of smoking onset (ONSET) at ≤1e-2 (red dots), ≤1e-3 (blue dots), ≤1e-4 (green dots), and ≤1e-5 (black dots). and Methods), where we were particularly interested in hypothesis 4 (H4: the two phenotypic traits were caused by the same SNP in the locus), and H4 posterior probability over 0.75 was considered as supporting evidence to the corresponding hypothesis 29, 30 . All the three LF adj trait (FEV 1 , FVC and FEV 1 /FVC Ratio) were co-localized at 15q25.1 (Table 7) , indicating they are controlled by the same genetic variant. The cigarettes per day and former smoking traits were also co-localized with LF adj (Table 8 ). For example, between CPD and FEV 1 , the coloc H 4 posterior probability was 0.908, and between former smoking and FEV 1 , the coloc H 4 posterior probability was 0.942. The clear co-localization of LF adj and ND at 15q25.1 suggested same genetic variant influence both nicotine dependence and lung function, through an independent pleiotropy model.
Discussion
In this report, we leverage the latest large GWAS data sets and investigated the genetic pleotropic effect between nicotine dependence and respiratory outcomes (ie, lung function and COPD). It is known smoking is a major cause of reduced lung function and COPD 8 . Smoking behavior is at least partially controlled by genetic factors 7, 9 . To date, the pleiotropic effects of genetic risk of smoking behavior and lung function/COPD have not been systematically explored. Employing several analytical approaches, this paper addressed two questions, (1) whether the genetic predisposition of nicotine dependence influence COPD risk and lung function; and (2) the genetic pleiotropy follow causal or independent model (Fig. 1) . On COPDgene cohort, we found the polygenic score of nicotine dependence (ie, PGS ND ) was associated with COPD case/control status, demonstrating the genetic pleiotropy of the two conditions. We also investigated the association between PGS ND and COPD while adjusting smoking behavior. Interestingly, the crude and adjusted results were very similar, indicating a mainly independent pleiotropy model. That is the shared genetic factors directly modify COPD risk, not mediated by influencing the individual's smoking behavior.
We zoomed in the known ND loci of genome-wide significance (Table 4) , and found both causal and independent pleiotropy models may exist in certain loci. Two genome-wide significant ND loci (15q25.1 and 19q13.2) were associated with LF adj (smoking adjusted lung function), supporting independent pleiotropy model. While, four ND loci (10q23.32, 8p11.21, 11p14.1 and 9q34.2) were not associated with smoking adjusted lung function. At various p value threshold (1e-6 to 1e-1), we found the LF adj traits share association SNP with cigarettes per day and former smoking substantially more than random chance, indicating a large number of genetic variants contribute to the genetic pleiotropy. Importantly, the lung function and cigarettes per day mainly share SNPs of divergent direction, meaning genetic predisposition of higher smoking dosage leads to lower lung function. In contrast, the lung function and former mainly share SNPs of consistent direction, meaning genetic predisposition of smoking cessation leads to higher lung function.
In summary, we used empirical data of largest cohorts to date and showed the genetic pleiotropy between nicotine dependence and COPD or lung function. The pleiotropic effect exist even COPD status or lung function is adjusted for smoking behavior. Further, we found the pleiotropic effect is attributable not only to the genome-wide significant loci, but also loci associated to ND and COPD/LF at suggestive p value (e.g. 1e-3), suggesting a large number of variants influence both ND and respiratory outcome, and among which many variants functions through independent genetic pleiotropy model.
Materials and Methods

Genome-wide meta-analyses on nicotine dependence (ND). The Tobacco and Genetics (TAG)
Consortium conducted GWAS meta-analyses across 16 studies 10 . We examined four carefully harmonized smoking phenotypes: smoking initiation (ever versus never been a regular smoker), age of smoking initiation, smoking quantity (number of cigarettes smoked per day, CPD) and smoking cessation (former versus current smokers) among people of European ancestry. Smoking cessation contrasted former versus current smokers, where current smokers reported at interview that they presently smoked and former smokers had quit smoking at least 1 year before interview. Smokers who had quit smoking for less than 1 year at interview were excluded from the analysis to minimize misclassification. Genotype imputation resulted in a common set of ~2.5 million SNPs that entered the GWAS and meta-analysis, where summary statistics were used in this report.
COPDGene dataset. Individual Table 5 ) and prune the SNPs by linkage disequilibrium (LD) based on 1000 G EUR reference; lastly (4) for each ND traits, and for each p value threshold, we computed a PGS for every subject as a linear combination of the imputed doses of the selected coefficients. Then we tested the association between nicotine dependent PGS and COPD case/control status using a logistic regression model with or without adjusting for smoking covariates.
Identification of SNPs associated with both LF and ND.
The effect size attributable to individual genetic variants for a given complex disorder is typically modest, suggesting that individual genetic variants may only explain a very small amount of the genetic risk and heritability of complex disorders 21, 31 . Therefore, genetic contributions to complex conditions such as LF and ND are likely derived from a large number of genetic causal variants, each contributing a small genetic risk. We surveyed a number of p value thresholds, and identified SNPs that are associated with LF adj and ND in order to more comprehensively capture SNPs with modest effect sizes. For a shared SNP, we term it "consistent allele direction" if a specific allele that is associated with increased LF adj traits and that specific SNP allele is also associated with higher ND trait value or event odds. We term "divergent allele direction" for SNP where a specific allele associated with increased lung function, and lower ND trait value or ND event odds.
Pathway Enrichment Analyses.
To further characterize the regulatory nature, enrichment analysis of the genes influenced by shared SNPs were performed using the METACORE integrated software suite (http://thomsonreuters.com/metacore/).
Co-localization of lung function and nicotine dependence GWAS top SNPs. LF adj and ND
GWAS results were used in co-localization analysis, which is performed using COLOC version 2.3-6 in R 28 . Our analysis focuses on the 15q25.1 locus. Default priors of the software were used. In total, 5 hypotheses were evaluated. H0: No association with either trait 1 or trait 2; H1: Association with trait 1, not with trait 2; H2: Association with trait 2, not with trait 1; H3: Association with trait 1 and trait 2, two independent SNPs; H4: Association with trait 1 and trait 2, one shared SNP. Genes that demonstrated a high posterior probability of hypothesis 4 (PP.H4 > 75%) indicate the disease risk and placenta gene expression were controlled by the same genetic variant; and genes that demonstrated a high posterior probability of hypothesis 3 (PP.H3 > 75%) indicate the disease risk and placenta gene expression were controlled by distinct genetic variant at the locus.
